Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | May 29, 2025 |
| Number of Shares Purchased | 797,583 |
| Highest Price Paid (p) | 418.00 |
| Lowest Price Paid (p) | 412.50 |
| Volume Weighted Average Price (p) | 415.90 |
| Registered Share Capital Post-Transaction | 9,006,127,704 shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,002,047,499 |
Material Changes
Following the settlement of the repurchase, the number of ordinary shares with voting rights decreased to 9,002,047,499. The filing notes that this figure is the basis for shareholders to determine notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities. A full breakdown of individual trades is referenced as available via the London Stock Exchange and the company's investor website.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the Buyback Programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full trade breakdown at the provided RNS link for intraday pricing details.
- Check the company's website for updated capital structure disclosures.